Zimbabwe has rejected a significant American healthcare agreement worth $367m (£272m) over five years due to Washington's request for sensitive data.
The decision was revealed following a official document dated December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "lopsided".
An official representative later stated that the United States was seeking biological samples for research and profit but refused to guarantee the benefits from future medical innovations.
"We will now turn to the difficult and regrettable task of ending our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy noted the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for further dialogue to secure a deal acceptable to both sides so the country's vital HIV programme can be sustained.
Broader Background
This development follows a comparable case in Kenya, where a high court halted a similar health funding agreement following concerns were filed about the security of citizens' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing government-to-government deals to boost transparency and responsibility.
As per reports, 16 nations in Africa have to date agreed to similar health pacts, representing more than $18.3bn of fresh investment.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this partnership could have provided immense advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy via US-supported programmes," the Ambassador said.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, with no equivalent promise of benefiting from any medical innovations – such as new medicines or tests – that could result from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for scientific discovery with no assurance that the end products would be available to our population should a future pandemic arise."
National Interest and International Frameworks
Mangwana further noted that the American exit from the global health body and its push of bilateral health agreements were upending frameworks previously set up via the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing framework created to deal with future pandemics.
"This system is intended to guarantee that when a country contributes its information, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
The government's concerns over the US deal "are not meant as opposition to America," Mangwana stressed.
"We encourage further dialogue with our US partners on how subsequent co-operation could be arranged in a way that honours the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that negotiations need to persist since a large portion of the country's Aids initiatives depended on international support.
"Where technical issues exist, including those involving data governance or implementation frameworks, these can often be addressed through detailed discussion and negotiated safeguards," it added.
The situation emphasises the continuing challenges between receiving vital international aid and safeguarding a country's data in an increasingly data-driven world.